Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study
Bonnet G, Bimba J, Chavula C, Chifamba H, Divala T, Lescano A, Majam M, Mbo D, Suwantika A, Tovar M, Yadav P, Ekwunife O, Mangenah C, Ngwira L, Corbett E, Jit M, Vassall A. Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study. PLOS Medicine 2024, 21: e1004429. PMID: 39024370, PMCID: PMC11293649, DOI: 10.1371/journal.pmed.1004429.Peer-Reviewed Original ResearchConceptsEffects of corticosteroidsMiddle-income countriesCOVID-like illnessCountry income levelInfluenza prevalenceSide effectsHigh index of suspicionSide effects of corticosteroidsInterleukin-6 receptor blockerIndex of suspicionImpact of corticosteroidsRapid diagnostic testsSARS-CoV-2Level of suspicionTreatment of patientsTesting of patientsStandard of careNegative test resultsCoronavirus diseaseHealthcare provider perspectiveSevere influenzaCOVID testingLower-middle-income countriesInfluenza outcomesInfluenza cases
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply